Home
Resources
Diseases
Training
SYSVAC
About
Registry
E-learning courses
News
Events
Network
Vision and Mission
Steering Committee
Map
Meetings
Join us
Home
Resources
Resources
Selected
COVID-19
NITAG documentation
2021
Background paper
Clear all
Type of publications
NITAG documentation
(27)
Topics
Background paper
(27)
Regions
Americas
(26)
Europe
(1)
Countries
Diseases
COVID-19
(27)
Vaccine topics
Target population
Methodological quality (AMSTAR 2)
Publication date
2021
(27)
2022
(9)
2020
(48)
Available to download in languages
English (EN)
(27)
27 results found
2021
∙
ACIP
Adverse events among children ages 5–11 years after COVID-19 vaccination: updates from v-safe and the Vaccine Adverse Event Reporting System (VAERS)
2021
∙
ACIP
COVID-19 Vaccine Safety Technical (VaST) Work Group
2021
∙
ACIP
Update on Omicron Variant
2021
∙
ACIP
Updates on Thrombosis with Thrombocytopenia Syndrome (TTS)
2021
∙
ACIP
Updates to the benefit/risk assessment for Janssen COVID-19 vaccines
2021
∙
ACIP
ACIP Evidence to Recommendations for Use of Janssen COVID-19 Vaccine under an Emergency Use Authorization
2021
∙
Sara Oliver, ACIP
ACIP Work Group interpretations of data
2021
∙
ACIP
AstraZeneca COVID-19 vaccine (AZD1222)
2021
∙
Fleming-Dutra, K. E., ACIP
CDC plans for COVID-19 vaccine effectiveness evaluation post-authorization and post-licensure
2021
∙
Public Health England
comparison between 1 and 2 dose prioritisation for a fixed number of doses
Home
Resources
Diseases
Training
SYSVAC
News
Events
Network
Sign in / Register